Ari Ristimäki Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

1/2021	Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis.
9/2016	HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors.
9/2012	Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice.
12/2011	Cyclooxygenase-2 and gastric cancer.
9/2011	Gastric cancer: basic aspects.
1/2010	COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.
1/2009	Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.
3/2008	Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.
3/2008	Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
9/2006	Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ari Ristimäki Research Topics

Disease

77	Neoplasms (Cancer) 07/2022 - 02/2002
29	Carcinogenesis 01/2021 - 02/2002
14	Adenocarcinoma 07/2022 - 02/2002
14	Stomach Neoplasms (Stomach Cancer) 06/2015 - 02/2002
13	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2008
12	Breast Neoplasms (Breast Cancer) 09/2017 - 02/2002
11	Inflammation (Inflammations) 01/2022 - 01/2004
11	Carcinoma (Carcinomatosis) 01/2015 - 06/2002
10	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2002
7	Adenoma (Adenomas) 01/2021 - 06/2003
6	Microsatellite Instability 05/2021 - 04/2008
5	Pseudomyxoma Peritonei 01/2021 - 08/2014
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 05/2021 - 01/2015
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022 - 10/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2003
3	Polyps 01/2009 - 04/2008
2	Disease Progression 01/2022 - 01/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2021
2	Residual Neoplasm 01/2022 - 10/2021
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2021 - 09/2009
2	Pouchitis 10/2021 - 01/2021
2	Ulcerative Colitis 10/2021 - 10/2016
2	Rectal Neoplasms (Rectal Cancer) 01/2020 - 01/2020
2	Ameloblastoma 05/2019 - 04/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2017 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 04/2016 - 02/2015
2	Kidney Neoplasms (Kidney Cancer) 01/2016 - 01/2010
2	Sarcoma (Soft Tissue Sarcoma) 02/2015 - 07/2005
2	Barrett Esophagus (Barrett's Esophagus) 01/2014 - 06/2002
1	Esophageal Neoplasms (Esophageal Cancer) 07/2022
1	Atrophy 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hypersensitivity (Allergy) 01/2022

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
28	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 02/2002
14	Messenger RNA (mRNA)IBA 09/2016 - 02/2002
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2008
6	Calcibiotic Root Canal SealerIBA 01/2021 - 04/2008
6	EnzymesIBA 10/2016 - 05/2005
6	ELAV-Like Protein 1IBA 09/2016 - 11/2003
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2005 - 02/2002
5	Formaldehyde (Formol)FDA Link 05/2021 - 03/2005
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2019 - 01/2015
5	Cadherins (E-Cadherin)IBA 06/2015 - 04/2006
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2012 - 02/2002
4	RNA (Ribonucleic Acid)IBA 11/2021 - 02/2015
4	ParaffinIBA 05/2021 - 03/2005
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 08/2003
4	DNA (Deoxyribonucleic Acid)IBA 03/2015 - 07/2003
4	Progesterone Receptors (Progesterone Receptor)IBA 09/2011 - 07/2005
3	Polysaccharides (Glycans)IBA 01/2021 - 11/2018
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 12/2019
3	Carrier Proteins (Binding Protein)IBA 09/2016 - 01/2008
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 06/2010
3	CytokinesIBA 01/2016 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2010
3	Trefoil Factor-1IBA 09/2012 - 06/2003
3	Pharmaceutical PreparationsIBA 09/2012 - 06/2003
3	Celecoxib (Celebrex)FDA Link 09/2012 - 06/2003
3	MicroRNAs (MicroRNA)IBA 09/2012 - 04/2010
3	Biological ProductsIBA 09/2011 - 01/2005
3	Estrogen ReceptorsIBA 09/2011 - 08/2003
3	Hormones (Hormone)IBA 07/2005 - 02/2002
2	CateninsIBA 01/2022 - 06/2015
2	LigandsIBA 01/2021 - 01/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 09/2010
2	MucinsIBA 11/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 04/2006
2	C-Reactive ProteinIBA 03/2018 - 01/2018
2	AntibodiesIBA 01/2017 - 09/2016
2	Sunitinib (Sutent)FDA Link 01/2017 - 01/2016
2	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 01/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2010
2	Monoclonal AntibodiesIBA 02/2015 - 06/2002
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 09/2011
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2009 - 11/2003
2	Vascular Endothelial Growth Factor CIBA 06/2006 - 03/2005
2	Small Interfering RNA (siRNA)IBA 10/2005 - 11/2003
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2004 - 02/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2002 - 02/2002
2	Protein Isoforms (Isoforms)IBA 06/2002 - 02/2002
1	eprenetapoptIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022

Therapy/Procedure

24	Therapeutics 04/2022 - 08/2008
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2015
3	Neoadjuvant Therapy 01/2022 - 10/2020
3	Immunotherapy 02/2015 - 11/2014
2	Metastasectomy 01/2022 - 01/2022
2	Fecal Microbiota Transplantation 10/2021 - 01/2021
2	Ligation 01/2021 - 01/2019
2	Palliative Care (Palliative Therapy) 10/2020 - 01/2016
2	Radiotherapy 01/2020 - 01/2016
2	Aftercare (After-Treatment) 01/2016 - 02/2015
2	Chemoprevention 03/2008 - 07/2005
1	Lymph Node Excision (Lymph Node Dissection) 07/2022
1	Esophagectomy 07/2022